已发表论文

肺癌脉络膜转移的综合认识

 

Authors Qu Z, Liu J, Zhu L, Zhou Q

Received 13 April 2021

Accepted for publication 27 July 2021

Published 12 August 2021 Volume 2021:14 Pages 4451—4465

DOI https://doi.org/10.2147/OTT.S315532

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr William CS Cho

Abstract: The incidence of lung cancer with intraocular metastasis is low, of which choroidal metastasis is the most painful metastatic lesion. The clinical symptoms resulting from choroidal metastasis from lung cancer easily detected although they are rarely identified prior to the diagnosis of the primary malignancy. The quality of life of patients is inevitably impaired. Some lung cancer patients complain of ocular symptoms as the first manifestation of lung cancer. Early diagnosis and treatment can significantly overcome or delay the visual impairment and improve prognosis. The main therapeutic modalities include systemic and local treatments, while observation is also a treatment option. Currently, the feasibility and effectiveness of various treatment options are controversial worldwide. Herein, we summarize the underlying mechanisms, epidemiology, clinical features, auxiliary examinations, diagnosis, and recent treatment options for intraocular metastases.
Keywords: intraocular tumor, cancer therapeutics, systemic therapy, local therapy